Amgen Net Change in Cash increased by 1020.6% to $2.91B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 192.0%, from -$3.16B to $2.91B. Over 2 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a 181.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests the company is accumulating liquidity, while a decrease indicates it spent more on investments, debt repayment, or operations than it generated in cash.
This metric represents the total increase or decrease in a company's cash, cash equivalents, and restricted cash over a...
This is a universal accounting standard used to reconcile the cash flow statement to the balance sheet across all industries and global peers.
net_change_in_cash| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $518.00M | $5.34B | -$1.46B | -$1.33B | $4.30B | -$1.87B | $23.93B | $2.69B | $493.00M | -$1.24B | -$407.00M | -$290.00M | $2.96B | -$3.16B | -$782.00M | $1.42B | -$316.00M | $2.91B |
| QoQ Change | — | +930.7% | -127.4% | +9.3% | +424.5% | -143.6% | >999% | -88.8% | -81.7% | -350.7% | +67.1% | +28.7% | >999% | -206.8% | +75.3% | +281.2% | -122.3% | >999% |
| YoY Change | — | — | — | -355.8% | -19.5% | — | >999% | +302.9% | -88.5% | -105.2% | -115.1% | -158.8% | — | -155.9% | -92.1% | +588.6% | -110.7% | +192.0% |